LobbyingPatients Act lobbying by quarter
Patients Act's latest lobbying report covers Q4 2025, at $90K. The four quarters Q3 2025–Q2 2026 total $140K. Its first report covers Q3 2025; the issues it reports most are Medical/Disease Research/Clinical Labs and Medicare/Medicaid.
Patients Act
- Latest quarter
- No record
- Q2 2026 · 0 reports
- Last 12 months
- $140K
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q3 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2025 | $50K | 1 |
| Q4 2025 | $90K | 1 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
Policy issues the reports name
- Medical research and clinical labs2 reports
- Medicare and Medicaid2 reports
A report that names several issues counts once for each.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)1 reports
- Health & Human Services, Dept of (HHS)1 reports
- White House Office1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Saluber Strategies | $140K | 2 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 01/20for Q4 2025 | Saluber Strategies | $90K |
| 25/10/20for Q3 2025 | Saluber Strategies | $50K |
| 25/10/20for Q3 2025 | Saluber Strategies | Under $5,000 |